Development of Novel, Biophysically Designed Fluids for Swallowing Disorders
1 other identifier
observational
200
1 country
2
Brief Summary
People suffering from swallowing disorders (dysphagia) have a hard time swallowing liquids that are too thin (like water or coffee) or too thick, correctly. They can have health problems, such as chest infections and malnutrition because when they try to drink, some of the liquid "goes down the wrong pipe" and into the lungs. To help people with dysphagia, Swallow Solutions is developing thickened liquids that have added nutrition, taste good, and quench thirst, but are still easy and safe to swallow.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2017
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 22, 2017
CompletedFirst Submitted
Initial submission to the registry
April 24, 2017
CompletedFirst Posted
Study publicly available on registry
April 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedApril 28, 2017
April 1, 2017
1.4 years
April 24, 2017
April 26, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Penetration - Aspiration Scale
presence of aspiration/penetration of the laryngeal vestibule
immediately while swallowing
Secondary Outcomes (1)
Post-swallow Residue
immediately while swallowing
Interventions
Thickened beverages in nectar consistency
Thickened beverages in honey consistency
Eligibility Criteria
Potential subjects will be adults with suspected dysphagia based on referral for a diagnostic videofluoroscopic swallowing evaluation. Only subjects who can consent for themselves will be enrolled in the study. The consent will take place before the swallow study begins. The study will include patients with a variety of medical etiologies to allow for greater generalizability of results. Pregnant women will be excluded from this protocol. Per standard clinical care (as all subjects will be completing the radiologic procedure regardless of participation in the study), pregnancy test will not be required.
You may qualify if:
- years of age or older
- physician approval of medical stability
- aspiration or penetration of the laryngeal vestibule (score of 3 or higher on the Penetration/Aspiration Scale) or post-swallow residue in the oropharynx as instrumentally documented by a Speech-Language Pathologist (SLP) during a standard videofluoroscopic oropharyngeal swallow study
- capacity to provide informed consent.
You may not qualify if:
- poorly controlled psychosis (3 or more related hospitalizations in one year
- refractory alcoholism (on AWD precautions)
- allergy to barium (used in radiographic swallowing assessment)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Swallow Solutionslead
- National Institute of Nursing Research (NINR)collaborator
Study Sites (2)
Meriter Hospital
Madison, Wisconsin, 53715, United States
Marshfield Clinic
Marshfield, Wisconsin, 54449, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eric Horler, MBA
Swallow Solutions
- PRINCIPAL INVESTIGATOR
JoAnne Robbins, PhD
Swallow Solutions
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2017
First Posted
April 27, 2017
Study Start
February 22, 2017
Primary Completion
July 1, 2018
Study Completion
July 1, 2018
Last Updated
April 28, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share